Key Laboratory of Basic Pharmacology of Ministry of Education & Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, 563003, China.
Department of Clinical Pharmacy, School of Pharmacy, Zunyi Medical University, Zunyi, 563003, China; Department of Pharmacology and Chemical Biology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Toxicol Lett. 2022 Mar 1;357:84-93. doi: 10.1016/j.toxlet.2022.01.001. Epub 2022 Jan 10.
The association of herb medicine Cortex Dictamni (CD) with severe even fatal hepatotoxicity has been widely reported. Recently, we demonstrated that the metabolic activation of at least ten furanoids in CD was responsible for the liver injury caused by the ethanol extract of CD (ECD) in mice. Protein adduction by reactive metabolites is considered to initiate the process of liver injury. Unlike single chemicals, the mode of and the details of protein modification by multiple components in an herb is unclear. This study aimed to characterize protein adductions derived from the reactive metabolite of furanoids in ECD-treated mice and define the association of protein adduction with liver injury. The hepatic cysteine- and lysine-based protein adducts derived from epoxide or cis-enedione of at least six furanoids were identified in mice. The furanoids with an earlier serum content T were mainly to bind with hepatic glutathione and no protein adducts were formed except for dictamnine. The hepatic proteins were modified by the later absorbed furanoids. The levels of hepatic protein adduct were correlated with the degree of liver injury. In addition, the reactive metabolites of different furanoids can simultaneously bind to the model peptide by the identical reactive moiety, indicating the additive effects of the individual furanoids in the modification of hepatic proteins. In conclusion, hepatic protein adduction by multiple furanoids may play a role in ECD-induced liver injury. The earlier absorbed furanoids were mainly to bind with glutathione whereas the hepatic proteins were modified by the later furanoids.
中药白鲜皮(CD)与严重甚至致命的肝毒性相关的报道已经很广泛。最近,我们证明了 CD 的至少十种呋喃类化合物的代谢激活是导致 CD 乙醇提取物(ECD)在小鼠中引起肝损伤的原因。活性代谢物与蛋白质的加合物被认为是引发肝损伤的过程。与单一化学物质不同,多成分草药中蛋白质修饰的方式和细节尚不清楚。本研究旨在表征 ECD 处理的小鼠中呋喃类化合物的活性代谢物衍生的蛋白质加合物,并确定蛋白质加合物与肝损伤的关联。在 ECD 处理的小鼠中鉴定出至少六种呋喃类化合物的环氧或顺-烯二酮衍生的半胱氨酸和赖氨酸基蛋白质加合物。具有较早血清含量 T 的呋喃类化合物主要与肝谷胱甘肽结合,除白鲜碱外,没有形成蛋白质加合物。后来吸收的呋喃类化合物修饰了肝蛋白。肝蛋白加合物的水平与肝损伤的程度相关。此外,不同呋喃类化合物的活性代谢物可以通过相同的活性部分同时与模型肽结合,表明个体呋喃类化合物在修饰肝蛋白方面具有加性作用。总之,多种呋喃类化合物的肝蛋白加合物可能在 ECD 诱导的肝损伤中起作用。较早吸收的呋喃类化合物主要与谷胱甘肽结合,而肝蛋白则被后来的呋喃类化合物修饰。